William Blair Downgrades VNUS Medical (VNUS) to Market Perform
VNUS Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 7 | New: 22
William Blair downgrades VNUS Medical (Nasdaq: VNUS) from Outperform to Market Perform.
VNUS Medical Technologies, Inc. develops, manufactures and licenses products used in the minimally invasive treatment of venous reflux disease, including disposable endovenous catheters and radio-frequency (RF) generators.
To see more analyst ratings on VNUS Click Here.
VNUS Medical Technologies, Inc. develops, manufactures and licenses products used in the minimally invasive treatment of venous reflux disease, including disposable endovenous catheters and radio-frequency (RF) generators.
To see more analyst ratings on VNUS Click Here.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- KeyBanc Downgrades Lululemon Athletica Inc. (LULU) to Hold; Valuation Call & Slight Concern of U.S. Slowdown
- Wedbush Downgrades Maxwell Technologies (MXWL) to Neutral; Elevated Competitive and Supply Chain Risks
Create E-mail Alert Related Categories
DowngradesRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
